129 related articles for article (PubMed ID: 1717874)
1. 8-hydroxy-2-(di-N-propylamino)tetralin increases the activity of adenylate cyclase in the hippocampus of freely-moving rats.
Sijbesma H; Schipper J; Molewijk HE; Bosch AI; de Kloet ER
Neuropharmacology; 1991 Sep; 30(9):967-75. PubMed ID: 1717874
[TBL] [Abstract][Full Text] [Related]
2. Serotonin 5-HT1A receptor activation increases cyclic AMP formation in the rat hippocampus in vivo.
Cadogan AK; Kendall DA; Marsden CA
J Neurochem; 1994 May; 62(5):1816-21. PubMed ID: 8158132
[TBL] [Abstract][Full Text] [Related]
3. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
[TBL] [Abstract][Full Text] [Related]
4. Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin.
Rabin RA; Winter JC
Eur J Pharmacol; 1993 Apr; 235(2-3):237-43. PubMed ID: 8508905
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxytryptamine receptor agonists influence calcium-stimulated adenylate cyclase activity in the cerebral cortex and hippocampus of the rat.
Mørk A; Geisler A
Eur J Pharmacol; 1990 Jan; 175(3):237-44. PubMed ID: 2138981
[TBL] [Abstract][Full Text] [Related]
6. Behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in monkeys.
Mizuta E; Yamaguchi M; Kuno S
Eur J Pharmacol; 1990 Mar; 178(1):125-7. PubMed ID: 2139614
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers.
Oksenberg D; Peroutka SJ
Biochem Pharmacol; 1988 Sep; 37(18):3429-33. PubMed ID: 2971358
[TBL] [Abstract][Full Text] [Related]
8. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
Hjorth S; Sharp T; Hacksell U
Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
[TBL] [Abstract][Full Text] [Related]
9. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
[TBL] [Abstract][Full Text] [Related]
10. 5-Hydroxytryptamine1A receptors are linked to a Gi-adenylate cyclase complex in rat hippocampus.
Harrington MA; Oksenberg D; Peroutka SJ
Eur J Pharmacol; 1988 Sep; 154(1):95-8. PubMed ID: 2972552
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG
Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066
[TBL] [Abstract][Full Text] [Related]
12. Mediation of serotonin hyperalgesia by the cAMP second messenger system.
Taiwo YO; Heller PH; Levine JD
Neuroscience; 1992; 48(2):479-83. PubMed ID: 1318516
[TBL] [Abstract][Full Text] [Related]
13. The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(DI-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat.
Przegaliński E; Ismaiel AM; Chojnacka-Wójcik E; Budziszewska B; Tatarczyńska E; Błaszczyńska E
Neuropharmacology; 1990 Jun; 29(6):521-6. PubMed ID: 2143565
[TBL] [Abstract][Full Text] [Related]
14. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT.
Larsson LG; Rényi L; Ross SB; Svensson B; Angeby-Möller K
Neuropharmacology; 1990 Feb; 29(2):85-91. PubMed ID: 1691832
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
Fozard JR; Mir AK; Middlemiss DN
J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400
[TBL] [Abstract][Full Text] [Related]
16. Lack of stereoselectivity of 8-hydroxy-2(di-N-propylamino)tetralin-mediated inhibition of forskolin-stimulated adenylyl cyclase activity in human pre- and post-synaptic brain regions.
Palego L; Giromella A; Marazziti D; Giannaccini G; Borsini F; Bigazzi F; Naccarato AG; Lucacchini A; Cassano GB; Mazzoni MR
Neurochem Int; 2000 Mar; 36(3):225-32. PubMed ID: 10676857
[TBL] [Abstract][Full Text] [Related]
17. Chloroamphetamine did not prevent the effects of chronic antidepressants on 5-hydroxytryptamine inhibition of forskolin-stimulated adenylate cyclase in rat hippocampus.
Newman ME; Ben-Zeev A; Lerer B
Eur J Pharmacol; 1991 Jul; 207(3):209-13. PubMed ID: 1654266
[TBL] [Abstract][Full Text] [Related]
18. Activation of 5-HT receptors that stimulate the adenylyl cyclase pathway positively regulates IGF-I in cultured craniofacial mesenchymal cells.
Lambert HW; Weiss ER; Lauder JM
Dev Neurosci; 2001; 23(1):70-7. PubMed ID: 11173928
[TBL] [Abstract][Full Text] [Related]
19. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain.
Bonvento G; Scatton B; Claustre Y; Rouquier L
Neurosci Lett; 1992 Mar; 137(1):101-4. PubMed ID: 1385646
[TBL] [Abstract][Full Text] [Related]
20. Determination of brain concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin by liquid chromatography with electrochemical detection.
Perry KW; Fuller RW
Biochem Pharmacol; 1989 Oct; 38(19):3169-73. PubMed ID: 2530985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
